UNC13B variants associated with partial epilepsy with favourable outcome.
Jie Wang1,2, Jing-Da Qiao1,2, Xiao-Rong Liu1,2
1Institute of Neuroscience and Department of Neurology of the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China.
Genetic variants in the UNC13B gene are linked to partial epilepsy. This research identifies UNC13B mutations in epilepsy patients, suggesting a potential new cause for the condition. Further studies confirm the gene
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- The UNC13B gene encodes Munc13-2, a presynaptic protein crucial for synaptic vesicle function and neuronal excitability.
- The role of UNC13B mutations in human diseases, particularly epilepsy, remains largely unexplored.
Purpose of the Study:
- To investigate the potential association between UNC13B gene variants and partial epilepsy.
- To identify and characterize novel UNC13B mutations in a cohort of epilepsy patients.
Main Methods:
- Trio-based whole-exome sequencing was performed on 446 unrelated families with partial epilepsy.
- Identified UNC13B variants were analyzed computationally and functionally in Drosophila models.
- Variant frequencies were compared between patient and control cohorts (Han Chinese, East Asian, gnomAD).
Main Results:
- UNC13B variants were found in 12 individuals from eight families with partial epilepsy and/or febrile seizures.
- Computational modeling and Drosophila studies indicated that the identified variants impair UNC13B function.
- UNC13B variant frequency was significantly higher in epilepsy patients compared to control populations.
Conclusions:
- UNC13B is potentially associated with the development of partial epilepsy.
- UNC13B-related epilepsy presents with focal seizures and potential hippocampal abnormalities but shows a favorable outcome with treatment.
- This study highlights UNC13B as a novel genetic factor in epilepsy.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
